| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Internet and Businesses Online > Internet Marketing > Online Marketing Conference In Sydney Yields Interesting Results |
|
Advice You - Online Marketing Conference In Sydney Yields Interesting Results
This week I’m in Sydney invited as an “industry expert” at a national online marketing conference. I was honoured to be on the pan According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product el, give a workshop and present to a full and well represented conference. It was incredible to see how the industry has come suc ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in along way since I started optimising and email marketing in the 90’s. The results of major brands such as Virgin Blue, Interconti lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. nental Hotels and the QLD Tourism Commission were great case studies that really drilled home what works well in the online market here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ng space. Planning, measurable outcomes and reviewing campaigns were a major discussion point by Australian and international org d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro nisations. Campaigns and online initiatives that failed to work by most organisations were scrapped with another two or three read ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc y to replace poor results. The common cry by all presenters including myself was that offline marketing goals and initiatives nee easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ed to drive and align with online marketing goals and activities. The planning process is so critical to success and will enevitab nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically y drive more qualified leads and converstions for web sites. Measurable results from campaigns and online initiatives were also h and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ighlighted as a mandatory planning tool. None of the truly successful organisations at the conference failed in their target setti ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi g activities. Most delegates that did plan their measurable success used the conversion rate of customers as the key performance ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ndicator. Of course that inclused the interactivity of a user beit in sales, competition entries or subscriptions. One other nota dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ble factor that was not suprising at all was the use of email marketing. Newsletter formats were not well liked. Linking back to w cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin b sites with supporting information that allows users to select their preferred link from an email rather than being bombarded wit tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen too much inbox information was given the nod. Linking and segmentation strategies also were widely discussed. Further more the i t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel mportance of content to conversion was the most suprisingly consisten message. Back to basics seemed to be the overall theme of t ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust e conference that will really set a platform for online markeing success. The much talked about blogging phenomena got a mixed re y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ponse from the speakers which left the delegates a touch confused. The expert panel were unconvinced by blogging and so am I so I . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de have decided that the best way to find out was to create a blog myself. It is an e-marketing oriented blog so come and try your ha elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:From Loyal Customer to Loyal Advocate The Wonders Of Wordpress Blogging
|